Satellite Symposiums & Workshops

Pre-Conference Satellite Meetings

Osteoporosis: diagnosis, management and therapy

Date: Saturday 17 June 2017

Time: 10:30am - 2:00pm

Location: A2

Precis: On the 17th of June there will be a pre-meeting satellite symposium dedicated to the Diagnosis, Management and Therapy of Osteoporosis. This session is designed for clinicians who treat patients with osteoporosis and trainees. This will be an informal interactive session bringing together eminent clinicians from Australia/New Zealand and overseas outlining practical approaches to osteoporosis care. The session will take a practical approach to the diagnosis of osteoporosis and assessment of fracture risk, approaches to treatment, and aspects of service organisation and osteoporosis prevention.

This session is complimentary, however you must sign up for it via your conference registration here.


 

The Genetics of Bone Disease: practical approaches and applications

Date: Saturday 17 June 2017

Time: 9:30am - 11:30am

Location: A1

Precis: This symposium will appeal to anyone seeking a better understanding of how biological and statistical approaches can be used to study the genetics of osteoporosis and related bone diseases. Each talk consists of a short theoretical component that introduces a statistical-genetic or molecular method and thereafter discusses its application to genetic investigations of bone disease. The symposium has been divided into two parts. In part one, we will describe the genetic underpinnings of mono- and polygenetic bone disease, and discuss how genome-wide association methods together with functional studies of model organisms can identify genetic elements involved in bone homeostasis. In part two, we discuss how the results of genetic association studies can be leveraged to identify novel therapeutic and lifestyle interventions.

Symposium Chairs:
Aideen Mclnerney-Leo (Queensland University of Technology) and John Kemp (University of Queensland)

Part 1: Investigating the Genetic Architecture of osteoporosis and related bone diseases.

09:30 - 09:45: The genetic architecture of bone disease and implications for adverse outcomes.

Speaker: Prof Emma Duncan (Queensland University of Technology)

09:50 - 10:05: Genetic investigations of monogenic bone disease using exome sequencing.

Speaker: Dr Aideen Mclnerney-Leo (Queensland University of Technology)

10:10 - 10:25: Genetic investigations of osteoporosis using genome-wide association studies.

Speaker: A/Prof Paul Leo (Queensland University of Technology)             

10:30 - 10:45: Fine mapping and characterisation of osteoporosis associated genes through skeletal phenotyping of animal models.

Speaker: Mr Scott Youlten (Garvan Institute of Medical Research)

Part 2: Application of Genetic Studies for Osteoporosis Intervention

10:50 - 11:05: Informing drug discovery and drug repositioning through genetic association studies.

Speaker: Prof Matt Brown (Queensland University of Technology)

11:10 - 11:25: Leveraging Mendelian randomization strategies to identify modifiable lifestyle factors causally related to osteoporosis pathogenesis.

Speaker: Prof David Evans (University of Queensland)


This session is complimentary, however you must sign up for it via your conference registration here.


 

Bone quality: what is it and how do we measure it?

Date: Saturday 17 June 2017

Time: 12:00pm - 2:00pm

Location: A1

The objective of this workshop is to discuss the current understanding of bone quality and different approaches that can be employed to measure it. Bone is a hierarchical, complex composite structure and depending on the scale and methods used to interrogate it, it will give corresponding answers. The talks in this workshop will range from a clinical to a laboratory perspective, including imaging, material and mechanical characterisation, each with their advantages and limitations. It is intended to be an interactive workshop, aimed at generating discussions and exchanging points of view among clinicians, bone biologists, engineers and physicists.

Chairs:
Egon Perilli (Flinders University, Adelaide), Christina Vrahnas (St. Vincent Institute/The University of Melbourne)


1. What determines bone quality and why is it important?
Ego Seeman (Austin Health/The University of Melbourne)

2. Bone histology: benefits, limitations and pitfalls
Natalie Sims (St. Vincent Institute/The University of Melbourne)

3. FTIR imaging in bone: what does it tell us?
Christina Vrahnas (St. Vincent Institute/The University of Melbourne) 

4. Other imaging approaches: Ultrasound
Christian Langton (Queensland University of Technology, Brisbane)

5. Mechanical testing combined with imaging
Egon Perilli (Flinders University, Adelaide) 

This session is complimentary, however you must sign up for it via your conference registration here.

Amgen Satellite Symposium

Date: Sunday 18 June 2017

Time: 1:00pm - 2:00pm

Location: B1 & B2

Speaker: Dr Richard Dell, Kaiser Permanente, California, USA

Dr Richard Dell is a practicing Orthopaedic Surgeon who joined Kaiser Bellflower (now Downey) in Southern California in 1987. He has a strong interest in both Osteoporosis Disease Management and Medical Informatics. He helped to start the Kaiser Southern California Healthy Bones program in 1998, and developed similar programs in Oregon, Hawaii, Virginia, Ohio, and Colorado. He has widely published the results of the Healthy Bones Osteoporosis Disease Management Program. He is the Kaiser National Orthopedic Lead for HealthConnect and serves on the Advisory Group for Clinical Services in Kaiser Southern California.

Title of talk: Fracture liaison service model of care: make the first fragility fracture the last

Precis: After a fragility fracture, approximately 20 percent of patients receive osteoporosis screening and/or treatment. Current models of care for osteoporosis and fracture prevention only work in locations that adopt a systematic approach for management of patients at risk of fracture or with previous fragility fracture. This presentation outlines best practice ideas from Fracture Liaison Service (FLS) programs in the UK, Canada, and the USA and focuses on the 10 steps needed to not only get a FLS started but also keep it going. 

This session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by     AmgenLogo Blue rgb WithoutTag v2

Teva Satellite Symposium

Date: Monday 19 June 2017

Time: 7:00am - 8:30am

Location: B1 & B2

Speaker: Bente Langdahl

Title of talk: Treating Osteoporosis – a personalised approach

Precis: Treatment of osteoporosis is often simple and straight forward, but can be challenging. Some patients do not respond, some patients stop treatment prematurely. A personalised approach to management of osteoporosis may help overcome some of these challenges. A personalised approach includes choice of treatment on the basis of the severity of the disease and planning and adequately monitoring treatment and treatment breaks. 


This session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by     teva logo

 

Lilly Satellite Symposium

Treating Patients with Severe Osteoporosis - What's New?

Date: Monday 19 June 2017

Time: 1:00pm - 2:00pm

Location: B1 & B2

Speaker: Dr Astrid Fahrleitner-Pammer & Professor Peter Ebeling

Topic 1: Recent Evidence on the Mechanisms of Action of Osteoporosis Drugs with Histomorphometry

Topic 2: Treating Severe Osteoporosis Patients with Teriparatide: A Clinical

This session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised byEli Lilly logo

Alexion Satellite Symposium

Date: Tuesday 20 June 2017

Time: 7:00am - 8:30am

Location: B1 & B2

Speaker: Professor Ravi Savarirayan & Professor Peter Ebeling

Title of talk: Differentiating hypophosphatasia (HPP) from other skeletal dysplasias in adults & children

Precis: A presentation of the key features of HPP, relative to other bone diseases, at varying ages from antenatal to adulthood & case studies demonstrating the management of HPP including intervention with asfotase alfa.

Topic 1: Differentiating HPP from other bone diseases

Topic 2: Case studies of patients with HPP & their treatment

This session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by Alexion

 

 


Our Sponsors